Related Experiment Videos
Effect of superparamagnetic iron oxide on bone marrow
W Hundt1, R Petsch, T Helmberger
1Department of Diagnostic Radiology, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Germany.
European Radiology
|September 21, 2000
Summary
Superparamagnetic iron oxide (SPIO) particles significantly impact liver and bone marrow MRI signal intensity less in liver cirrhosis patients. This finding is crucial for accurate MRI interpretation in patients with liver disease.
Area of Science:
- Radiology and Imaging Science
- Hepatology and Liver Disease Research
- Biomedical Engineering and Medical Physics
Background:
- Superparamagnetic iron oxide (SPIO) particles are used as MRI contrast agents, altering signal intensity in various tissues.
- Liver cirrhosis affects liver function and can potentially influence the biodistribution and effects of contrast agents.
- Understanding SPIO particle effects on bone marrow signal intensity is important for interpreting spinal MRI in patients with liver disease.
Purpose of the Study:
- To compare the impact of SPIO particles on vertebral bone marrow signal intensity in patients with and without liver cirrhosis.
- To evaluate the differences in SPIO-induced signal changes in the liver and bone marrow between cirrhotic and non-cirrhotic patients using various MRI sequences.
Main Methods:
- 48 patients with normal liver tissue and 56 with liver cirrhosis underwent MRI before and after intravenous SPIO administration on a 1.5-T system.
- Three pulse sequences were applied: T1-weighted gradient-echo, T2-weighted fast spin-echo (with fat suppression), and T2*-weighted gradient-echo.
- Signal-to-noise ratio (SNR) changes in the liver and bone marrow were analyzed, with statistical significance assessed using Student's t-test (p < 0.05).
Main Results:
- Precontrast, no significant SNR differences were observed in liver or bone marrow between groups.
- In non-cirrhotic patients, T1-weighted imaging showed decreased liver SNR (-44.3%) and increased bone marrow SNR (+15.3%).
- T2*-weighted imaging revealed significant liver SNR decreases in both groups (-65.6% non-cirrhotic, -29.9% cirrhotic) and bone marrow SNR decrease in non-cirrhotic patients (-27.8%), with less pronounced, non-significant changes in cirrhotic patients.
Conclusions:
- The effect of SPIO particles on liver and bone marrow signal intensity is significantly diminished in patients with liver cirrhosis.
- MRI interpretation of SPIO contrast enhancement in bone marrow requires consideration of the patient's liver status.
- These findings highlight the differential impact of SPIOs based on liver disease severity, influencing diagnostic accuracy.